On February 20, 2018, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy through its French subsidiary Apsis to develop its robot-assisted orthopedics surgery platform.
Johnson & Johnson (NYSE:JNJ) said its medical device business paid an undisclosed amount to acquire French robot-assisted surgery company Orthotaxy. Founded in 2009, Orthotaxy’s proprietary technology is currently in early-stage development for total and partial knee replacements. J&J plans to expand Orthotaxy’s technology into other orthopedic surgeries as part of its bid to create a new robot-assisted platform using “enabling technologies to personalize procedures, optimize surgery and bring value to customers and patients.” Read More
News & image reference: